Universal American ACOs and Fresenius Medical Care Partner to Improve Health of End Stage Renal Disease Patients
October 26 2016 - 8:30AM
Business Wire
Collaborative Health Systems (CHS), a Universal American company
(NYSE: UAM), and Fresenius Medical Care (NYSE: FMS), North
America’s largest provider of kidney care services, announced an
agreement today to provide integrated health care management for
patients with renal disease who are enrolled in seven Medicare
Shared Savings Program Accountable Care Organizations (MSSP ACOs)
operated by CHS and physician partners. Under the agreement, the
two companies will collaborate to improve outcomes and reduce the
total cost of care for renal patients. With its wealth of expertise
with this complex population, Fresenius Medical Care will manage
the identification, staging and care coordination of renal patients
who, with multiple comorbidities, comprise a significant portion of
total spending by MSSP ACOs.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20161026005423/en/
This innovative population health partnership is modeled on the
successful programs Fresenius Medical Care operates for more than
10,000 end stage renal disease (ESRD) patients and more than 5,000
chronic kidney disease (CKD) patients across the country. These
programs have delivered meaningful increases in the quality of care
for late stage CKD patients and reductions in hospitalization and
mortality rates for ESRD patients. Additionally, the jointly
developed protocols provide for enhanced collaboration between
primary care physicians and nephrologists in caring for and
coordinating services to address the complex needs of the renal
patient.
Jeff Spight, president of Collaborative Health Systems,
addressed the importance of the program. “As the healthcare system
shifts from fee-for-service to fee-for-value, we believe there are
many opportunities to improve health outcomes while reducing costs
for Medicare beneficiaries with renal disease. Not only do renal
patients have complex needs, they are a difficult group to
identify, making it challenging for providers in ACOs to coordinate
their care. We look forward to working with Fresenius Medical Care
as we discover new ways to improve the care quality of this
important population.”
“We are excited to become a strategic partner with Universal
American, Collaborative Health Systems and their ACO physician
partners to improve the quality of life and clinical outcomes for
people with renal disease,” said Ron Kuerbitz, CEO of Fresenius
Medical Care North America. “Collaborative Health Systems has
demonstrated its ability to effectively manage health care spending
across its ACO network, and we look forward to incorporating our
expertise in managing renal disease to further benefit its ACO
beneficiaries.”
About Collaborative Health
SystemsCollaborative Health Systems (CHS), a Universal
American company (NYSE: UAM), is a management services organization
that partners with primary care physicians as they move to
value-based payment systems. Our core belief is that primary care
physicians are in the best position to influence the quality and
cost of healthcare. CHS provides comprehensive support for its
physician partners by providing actionable data to help coordinate
care and helping practices change behavior to meet the new quality
requirements of the value-based payment system. CHS currently
manages one Next Generation ACO Model, and 22 MSSP ACOs, with
approximately 5,000 providers, mostly primary care physicians,
covering 239,000 Medicare beneficiaries. For more information,
visit www.CollaborativeHealthSystems.com.
About Universal American
Corp.Universal American (NYSE: UAM), through our family
of healthcare companies, provides health benefits to people covered
by Medicare. We are dedicated to working collaboratively with
healthcare professionals, especially primary care physicians, in
order to improve the health and well-being of those we serve and
reduce healthcare costs. For more information on Universal
American, please visit our website at
www.UniversalAmerican.com.
About Fresenius Medical Care North
AmericaFresenius Medical Care North America is the
premier health care company focused on providing the highest
quality care to people with renal and other chronic conditions.
Through its industry-leading network of dialysis centers,
outpatient cardiac and vascular labs, and urgent care centers, as
well as the continent’s largest practice of hospitalist and
post-acute providers, Fresenius Medical Care North America provides
coordinated health care services at pivotal care points for
hundreds of thousands of chronically ill customers. As the world’s
largest fully vertically integrated renal company, it offers
specialty pharmacy and laboratory services, and manufactures and
distributes the most comprehensive line of dialysis equipment,
disposable products, and renal pharmaceuticals. For more
information, visit www.FMCNA.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161026005423/en/
Fresenius Medical CareJon Stone, 781-699-9704 (o)781-392-4680
(cell)jonathan.d.stone@fmc-na.comorUniversal AmericanSarah Bell,
914-597-2908sbell@universalamerican.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024